Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Amazon Fear Grips Retail Pharmacy Space, Alliances Continue

By Zacks Investment ResearchStock MarketsJan 15, 2019 08:39PM ET
www.investing.com/analysis/amazon-fear-grips-retail-pharmacy-space-alliances-continue-200376158
Amazon Fear Grips Retail Pharmacy Space, Alliances Continue
By Zacks Investment Research   |  Jan 15, 2019 08:39PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

It seems that e-commerce giant Amazon's (NASDAQ:AMZN) entry in the pharmacy retail market along with other non-healthcare heavyweights like Berkshire Hathaway (NYSE:BRKa) and JPMorgan (NYSE:JPM) has initiated a new episode in the healthcare space. According to many market watchers, the traditional retail pharmacy and drugstore industry is set to undergo a sea change.

This development has been taken quite seriously by drugstore industry players who are unwilling to give up and lose their turf. These traditional pharmacy players are currently coming together to defend their position.

Consolidations in the Traditional Pharmaceutical and Drug Retail Space

After underperforming for a year, shares of Walgreens (NASDAQ:WBA) finally rallied 1.6% to close at $71.79 after the company entered into a seven-year alliance with Microsoft Corporation (NASDAQ:MSFT) .

The partnership will combine Microsoft Azure, Microsoft's cloud and AI platform, health care investments and new retail solutions, with Walgreen’s customer reach, convenient locations, outpatient health care services and industry expertise. According to a CNBC article, this alliance will explore digital health opportunities within stores and develop software for managing patient engagement.



While Amazon is trying to figure out ways to enter the multibillion dollar pharmacy industry, this is not the first attempt made by Walgreens to counter competition. Following Amazon’s foray into the healthcare retail industry last June (through the purchase of online pharmacy PillPack in December), Walgreens formed an alliance with Alphabet’s (NASDAQ:GOOGL) life sciences and healthcare segment, Verily, to collaborate on multiple projects. According to Walgreens, this strategic tie-up was designed to combine Verily’s healthcare technology innovation with Walgreens’ pharmacy services.

In this regard, we note that following Amazon’s PillPack deal, Walgreens CEO Stefano Pessina stated he was "not particularly worried" about Amazon. Walgreens currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Another established player CVS Health (NYSE:CVS) is also following Walgreens’ footstep. This Zacks Rank #1 PBM (pharmacy benefit manager) company achieved a momentous healthcare consolidation by acquiring United States’ third largest health insurer Aetna (NYSE:AET) for a colossal sum of $70 billion.

Last month, prominent health insurer Cigna (NYSE:CI) merged with PBM player, Express Scripts (NASDAQ:ESRX). This latest deal can effectively drive the breadth of value-based relationships for Cigna and add to its fast-growing collaborative care network.

Summing Up

In any business, bankable human resource and strong financial position matter the most. And Amazon has both. Undoubtedly, Amazon’s entry has resulted in an upheaval in the prescription drug industry with major players struggling to keep afloat.

However, some analysts believe those preferring cash payments are expected to opt for Amazon’s pharmacy services. However, the percentage of this population is quite nominal. Moreover, patients with the need for immediate drugs will prefer buying them from stores over waiting for online delivery.

Considering these factors, major analysts believe there is enough scope left for the existing industry behemoths to maintain a competitive edge.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



Original post

Zacks Investment Research
Amazon Fear Grips Retail Pharmacy Space, Alliances Continue
 

Related Articles

Amazon Fear Grips Retail Pharmacy Space, Alliances Continue

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email